Literature DB >> 31691165

Atypical Memory and Regulatory B Cell Subsets in Tumor Draining Lymph Nodes of Head and Neck Squamous Cell Carcinoma Correlate with Good Prognostic Factors.

Marzieh Norouzian1, Fereshteh Mehdipour2, Sima Balouchi Anaraki1, Mohammad Javad Ashraf3, Bijan Khademi4, Abbas Ghaderi5,6.   

Abstract

Research on the role of B cells in the development and modulation of antitumor immunity has increased in recent years; however, knowledge about B cell phenotype and function in tumor draining lymph nodes (TDLNs) is still incomplete. This study aimed to investigate changes in the phenotypic profile of B cells in TDLNs of head and neck squamous cell carcinoma (HNSCC) during disease progression. Mononuclear cells were isolated from TDLNs and stained with antibodies for CD19 and other B cell-related markers and analyzed by flow cytometry. CD19+ B cells comprised 38.6 ± 8.9% of lymphocytes in TDLNs of HNSCC. Comparison of metastatic and non-metastatic LNs disclosed no significant differences in the frequencies of B cell subsets including antigen-experienced, naïve, switched, unswitched, atypical memory, marginal zone-like B cells, and B cells with regulatory phenotypes. The percentage of atypical memory (CD27-IgM-IgD-) B cells was significantly higher in patients with tongue SCC with no involved LNs (p = 0.033) and correlated inversely with the number of involved LNs. The frequency of CD24hiCD38hi B cells was significantly higher in non-metastatic LNs of patients with grade I compared to grade II (p = 0.016), and the percentage of CD5+ B cells decreased as tumors progressed from stage III to IV (p = 0.008). Our data show that in TDLNs of HNSCC, the frequency of B cells with atypical memory and regulatory phenotypes was significantly associated with good prognostic factors; however, their function remains to be investigated.

Entities:  

Keywords:  B cells; HNSCC; Regulatory B cells; Tumor draining lymph nodes

Mesh:

Year:  2019        PMID: 31691165      PMCID: PMC7413970          DOI: 10.1007/s12105-019-01095-1

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  19 in total

1.  B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.

Authors:  Bernd Jahrsdörfer; Sue E Blackwell; James E Wooldridge; Jian Huang; Melinda W Andreski; Laura S Jacobus; Christiana M Taylor; George J Weiner
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

2.  B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.

Authors:  Massimo Ammirante; Jun-Li Luo; Sergei Grivennikov; Sergei Nedospasov; Michael Karin
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

3.  The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Authors:  Tamar Tadmor; Yu Zhang; Hyun-Mi Cho; Eckhard R Podack; Joseph D Rosenblatt
Journal:  Cancer Immunol Immunother       Date:  2011-01-21       Impact factor: 6.968

4.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Authors:  Yohei Iwata; Takashi Matsushita; Mayuka Horikawa; David J Dilillo; Koichi Yanaba; Guglielmo M Venturi; Paul M Szabolcs; Steven H Bernstein; Cynthia M Magro; Armistead D Williams; Russell P Hall; E William St Clair; Thomas F Tedder
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

5.  B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.

Authors:  David J DiLillo; Koichi Yanaba; Thomas F Tedder
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

6.  Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells.

Authors:  Sangeeta Shah; Anagha A Divekar; Shannon P Hilchey; Hyun-Mi Cho; Corliss L Newman; Seung-Uon Shin; Hovav Nechustan; Pia M Challita-Eid; Benjamin M Segal; Kyung Hee Yi; Joseph D Rosenblatt
Journal:  Int J Cancer       Date:  2005-11-20       Impact factor: 7.396

7.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Authors:  David H Munn; Madhav D Sharma; Deyan Hou; Babak Baban; Jeffrey R Lee; Scott J Antonia; Jane L Messina; Phillip Chandler; Pandelakis A Koni; Andrew L Mellor
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes.

Authors:  A Francesca Setiadi; Nelson C Ray; Holbrook E Kohrt; Adam Kapelner; Valeria Carcamo-Cavazos; Edina B Levic; Sina Yadegarynia; Chris M van der Loos; Erich J Schwartz; Susan Holmes; Peter P Lee
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  Phenotypic and functional characterization of human CD25+ B cells.

Authors:  Mikael Brisslert; Maria Bokarewa; Pia Larsson; Kajsa Wing; L Vincent Collins; Andrej Tarkowski
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

10.  Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.

Authors:  Holbrook E Kohrt; Navid Nouri; Kent Nowels; Denise Johnson; Susan Holmes; Peter P Lee
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

View more
  6 in total

1.  Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.

Authors:  Xin Feng; Tan Zhang; Jeff Chou; Liang Liu; Lance D Miller; Christopher A Sullivan; James D Browne
Journal:  Head Neck       Date:  2021-11-29       Impact factor: 3.147

2.  The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins.

Authors:  Ruijie Ming; Xiangrui Li; Enhao Wang; Jiahui Wei; Bo Liu; Peng Zhou; Wenting Yu; Shimin Zong; Hongjun Xiao
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

Review 3.  Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.

Authors:  María Velasco-de Andrés; Sergi Casadó-Llombart; Cristina Català; Alejandra Leyton-Pereira; Francisco Lozano; Fernando Aranda
Journal:  Cells       Date:  2020-12-03       Impact factor: 6.600

4.  Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences.

Authors:  Tao Fan; Chunxiang Li; Jie He
Journal:  Biol Sex Differ       Date:  2021-12-04       Impact factor: 5.027

Review 5.  Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses.

Authors:  Fabian Flores-Borja; Paul Blair
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

6.  Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.

Authors:  Simin Li; Yang Wang; Rui Sun; Debora Franceschi; Hongying Pan; Chenxuan Wei; Anthony Chukwunonso Ogbuehi; Bernd Lethaus; Vuk Savkovic; Sebastian Gaus; Rüdiger Zimmerer; Dirk Ziebolz; Gerhard Schmalz; Xiao Jiang
Journal:  J Immunol Res       Date:  2022-09-16       Impact factor: 4.493

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.